Human Colon Carcinoma Cell line (HT-29)
Red cotton OmniCell bank
10000+
Gene Knockout Cell Lines
|
2000+
Luc/EGFP/Cas9 Tool Cell Lines
|
1000+
Wild-type Cell Lines
Human Colon Carcinoma Cell line (HT-29)
Copy Product Info
Online inquireOverview
The HT-29 line was isolated from a primary tumor in 1964 by J. Fogh using the explant culture method.
Detailed Product Information
Human Colon Carcinoma Cell line (HT-29)
This cell line has a well-defined origin, a clean background, and broad applicability. It can be reliably used in basic research applications such as functional validation, signaling pathway analysis, and drug treatment.
Product name
Human Colon Carcinoma Cell line (HT-29)
Mycoplasma test
Negative
Catalog number
YC-C008
Cellosaurus ID
CVCL_0320
Product category
Wild-type Cell Lines
Shipping condition
Frozen vials; dry-ice package
Cell morphology
Epithelial-like, adherent
Storage condition
Liquid nitrogen
Culture Medium
90%McCOY's 5A+10% FBS
Species/Source
Human Colon Carcinoma Cell line
Passage ratio
1:2~1:4
Intended use
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
Sterility Testing
All cells have been tested and are free of bacteria, viruses, mycoplasma, and other toxins.
Recommended transfection method
Quality Control Specifications
1. Bacteria and fungi test
The test result was negative.
2. Mycoplasma test
The test result was negative.
3. STR Authentication
Intended use
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use
Unpacking and Storage Instructions
1.
Cell Reception
2.
Unpacking and storage instructions
Handling procedure
1.
Cell Thawing
2.
Cell Passaging
3.
Cell cryopreservation
References
FAQ
Q1. How to Contact Support if Issues Arise After Receiving the KO Cells?
If any abnormalities are observed after receiving the cells, please provide the following information based on the stage of use and contact us promptly for assistance:
(1) Issues upon delivery: Please provide photos of the cells at the time of receipt along with a brief description of the issue. We will offer after-sales support accordingly.
(2) Issues after thawing or passaging: Please provide microscopic images of the cells before and after thawing/passaging, along with a detailed description of the experimental procedures. Our technical team will provide professional support.
Q2. What Information Is Required When Reporting KO Cell Product Issues?
Q3. How Should the KO cell Product Be Stored Upon Receipt?
Q4. Shipping Method
Q5. Are the Knockout Cell Lines Stable for Passaging? Is Authentication Provided?
Related Popular Products
Stable Cell Lines
SQSTM1 Stable Expression Cell Line (HT-29)
EGFP Stable Cell Lines
HT-29-EGFP
Catalog#: YC-C008-EGFP-P
Size: 1*10^6
Resistance: puro
Classification: Digestive System
EGFP:
Instruction: 
Download
DownloadLuciferase Stable Cell Lines
HT-29-Luc
Catalog#: YC-C008-Luc-P
Size: 1*10^6
Resistance: puro
Classification: Digestive System
Price(USD): 1190990
Instruction: Download
Download
Cas9 Stable Cell Lines
HT-29-CAS9
Catalog#: YC-C008-Cas9-H
Size: 1*10^6
Resistance: hygro
Classification: Digestive System
Price(USD): 17901280
Instruction: Download
DownloadKO Cell Lines
ZNRD2 Knockout cell line (HT-29)
Organism: Human
Gene Name: ZNRD2
Gene ID: 10534
Size: 1*10^6
Catalog#: YKO-HA43231
ZNF875 Knockout cell line (HT-29)
Organism: Human
Gene Name: ZNF875
Gene ID: 284459
Size: 1*10^6
Catalog#: YKO-HA43230
ZMYM3 Knockout cell line (HT-29)
Organism: Human
Gene Name: ZMYM3
Gene ID: 9203
Size: 1*10^6
Catalog#: YKO-HA43229
Contact Us
Simply fill out the form below to leave your inquiry
— we will respond within 24 Hours
* Name
* Institution
* Products & Services of Interest
If email is not available, how else can we reach you?
How did you hear about us?
CRISPR Gene Editing Services
CRISPR Gene Editing Designer
E-mail: info@ubigene.com
WhatsAPP: +86 153 6067 3248
TEL: +86 153 6067 3248(Int'l)
EU Toll free: 800 3272 9252
US Toll free: 855 777 3210
Korea Toll free: 001 800 3272 9252
Copyright © 2025 Ubigene. All rights reserved.
